-
effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
January 01, 2009 - Comparator and Applicability: Examples
A fixed-dose study that compared high-dose duloxetine to low-dose … In the last example, bypass surgery and angioplasty are being compared. … Unfortunately, these clinical trials, by and large, compared bypass surgery versus angioplasty with or … If efficacy and effectiveness trials are available, they should be compared and contrasted. … We then give the conclusion: “When compared with watchful waiting, the use of myocardial debulking reduced
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_executive.pdf
March 01, 2014 - The differential diagnosis for chronic cough has a
different list of etiologies compared with acute … For KQ 1, the
search focused on English-language evaluative studies
that compared qualitative and/or … Most of
the studies compared the treatment with placebo, but one
compared opiates with dextromethorphan … The effects of
dextromethorphan, moguisteine, and opiates compared
with placebo on cough severity support … The effects of dextromethorphan
and codeine compared with placebo on cough frequency
support a benefit
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
April 01, 2011 - Too few studies isolated a
sufficient number of those with mild TBI compared to
those with moderate and … sevenfold as common
(95 percent CI: 1.36 to 43.48) among those with
abnormal CT scans after injury compared … only
lesion type to emerge as a significant predictor was the
protective effect of temporal lesions compared … Five
publications compared SCID to candidate tools for
assessment of depression, the BDI,90,115 Patient … Similarly, 17 of 30 (56.7
percent) depressed patients exhibited aggression,
compared to 10 of 44 (22.7
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
March 01, 2025 - disease (CVD) significantly
increased when carbohydrate intake exceeded 65 percent total energy intake,
compared … CVD significantly increased when carbohydrate intake exceeded 300 grams per
day of carbohydrates, compared … When
compared with a carbohydrate intake reference level of 50 percent total energy intake, a
digestible … Compared with the carbohydrate
intake reference level (300 grams per day), digestible carbohydrate intake … carbohydrate intake levels at the lowest CVD risk
(225 grams per day: RR=0.91, 95% CI: 0.87 to 0.96), compared
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_disposition-comments.pdf
May 24, 2013 - RFA compared to TACE would be outside of the
scope of this review generally because the patient populations … One study did present data on RFA
compared to TACE for patients with lesions that were all
amenable … The RFA
compared with TACE has been removed from this report with the
exception of one study. … Those procedures cannot be compared with
ablative therapies because they do not deal with
the same … Chok and colleagues
compared RFA to TACE in a patient population with tumor
diameters less than 5cm
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Experts thought that the
intervention would reduce per-patient treatment costs, compared with costs … Another research expert
noted that another clinical trial compared this intervention to behavior and … Experts thought reduced per-patient costs to be associated
with this intervention, compared with laser … photocoagulation but thought costs would be
significantly greater with this intervention when compared … DURATION-5: exenatide once weekly resulted in
greater improvements in glycemic control
compared with
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
September 01, 2011 - † Number of events reduced compared to placebo per 1,000 women years assuming 5 years of use (95% confidence … ‡ Number of events increased compared to placebo per 1,000 women years assuming 5 years of use (95% … treatment alternatives
o No existing alternative treatment
o Ease of use
o Improved access
o Cost compared
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_disposition-comments.pdf
January 01, 2012 - The incremental interventions that were
ineffective in general are ineffective or weakly effective compared … conclusion
accordingly: “SMBP with or without additional support
results in a small reduction in BP compared … as high in favor of an improvement
in BP control using SMBP with some form of additional
support compared … as high in favor of an improvement
in BP control using SMBP with some form of additional
support compared … as high in favor of an improvement
in BP control using SMBP with some form of additional
support compared
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - Experts agreed that ultra-long-
acting insulins have the potential to improve insulin therapy compared … Final mean daily
insulin dose was 11% lower for Ryzodeg® compared with biphasic insulin aspart 30 … Experts agreed that ultra-long-acting insulins have the potential to improve insulin
therapy compared … One expert representing a research perspective listed increased costs compared with available
therapy … Benefit
occurred for both doses compared with sham at 3 weeks and all subsequent time
points.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
December 16, 2014 - Pg. 11
We included any study that compared RP to
another treatment of interest, addressed the KQ
and … The treatments
being compared must have been administered
during the same time period, so that any … We considered studies which compared variants of
the same treatment as out of scope for this report. … The Aizer et al. 2013
study compared patients treated with curative
versus non-curative treatments … Lee et al. 201237 (study compared men with
prostate cancer vs. men who did not carry a
diagnosis of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-machine-learning-screening.pdf
November 01, 2019 - irrelevant records was highly
variable; a median (range) 70% (0-100%) of relevant records were missed compared … For the Automated Simulation, the proportion missed increased to 41 percent for
Antipsychotics (compared … with 28 percent) and 9 percent for Bronchiolitis (compared with 5
percent). … RobotAnalyst provided a lesser advantage compared to Abstrackr, and Distiller provided
no advantage … That said,
it requires much more skill to actually set up a project
in Distiller compared to the other
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - Comparator — What is the intervention being compared with? … What is the intervention being compared with? O is for outcomes. … growth (height, weight, lean body mass, protein turnover), exercise tolerance, and bone mineralization, compared … hospitalization, quality of life, bone fracture or development of osteoporosis/osteopenia, or mortality, compared … growth (height, weight, lean body mass, protein turnover), exercise tolerance, and bone mineralization, compared
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
September 30, 2010 - What is the comparative effectiveness of pharmacologic treatments when compared with
each other or with … What are the harms from pharmacologic treatments when compared with no active
treatment?
4. … What is the comparative effectiveness of nonpharmacologic treatments when compared
with each other? … What are the harms from nonpharmacologic treatments when compared with no active
treatment?
5. … What are the harms from nonpharmacologic treatments when compared with each other?
6.
-
effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
April 01, 2016 - imaging technique
with widespread availability, high contrast resolution,
and relatively low cost compared … For comparative accuracy (KQ1), the study must have
compared both tests to a common reference standard … the percentage of patients who
received a specific treatment choice for one test
or test strategy compared … One study compared FDG PET/CT to bone
scintigraphy;14 another study compared CT to FDG PET/
CT to bone … First, compared with CT
and bone scintigraphy (imaging modalities commonly used
for staging), FDG PET
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
January 01, 2024 - resulted in less labor costs and fewer undesirable shifts from the frontline nurse’s point of view compared … the quality of care they gave their patients and their ability to perform required/regulatory tasks compared … N=29754, standardized mortality ratio 1.20±0.04 to Post-mandate N=30058, 1.15±0.04, p=0.11) or when compared … For hospitals in Quartile 2, the only difference (as compared with Quartile 4) was in greater improvement … 2015), and 0.46 (2016) registered nurses hours per adjusted patient days located in expansion states, compared
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-d.xlsx
January 01, 2024 - 0.328 0.732 Using ExaCT to assist with data extraction resulted in modest gains in efficiency compared … 0.5 0.75 Using ExaCT to assist with data extraction resulted in modest gains in efficiency compared … 0.636 0.842 Using ExaCT to assist with data extraction resulted in modest gains in efficiency compared … 0.213 0.707 Using ExaCT to assist with data extraction resulted in modest gains in efficiency compared … 0.16 0.507 Using ExaCT to assist with data extraction resulted in modest gains in efficiency compared
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
July 21, 2014 - Bladder cancer occurs primarily in
men older than 60 and roughly twice as frequently in white compared … Key Question 1: What is the diagnostic accuracy of various urinary biomarkers compared
with other urinary … or improving other outcomes (e.g., recurrence, progression, need for
cystectomy, quality of life) compared … or with systemic chemotherapy/immunotherapy) for decreasing mortality or
improving other outcomes compared … is the effectiveness of various urinary biomarkers to decrease
mortality or improve other outcomes compared
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction-to-user-guide-overview.pptx
January 01, 2013 - validity
There are few standards for elements to be included in observational study protocols, when compared
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0495_05-24-2013.pdf
January 01, 2013 - scintigraphy, CT, MRI, x-ray, ultrasound, PET/CT and FDG-PET
Comparator(s): Those listed above (i.e., compared